Veterinary Drugs-EMEA Market Status and Trend Report 2013-2023
Report Summary
Veterinary Drugs-EMEA Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Veterinary Drugs industry, standing on the readers’ perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Whole EMEA and Regional Market Size of Veterinary Drugs 2013-2017, and development forecast 2018-2023
Main market players of Veterinary Drugs in EMEA, with company and product introduction, position in the Veterinary Drugs market
Market status and development trend of Veterinary Drugs by types and applications
Cost and profit status of Veterinary Drugs, and marketing status
Market growth drivers and challenges
The report segments the EMEA Veterinary Drugs market as:
EMEA Veterinary Drugs Market: Regional Segment Analysis (Regional Consumption Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
Europe
Middle East
Africa
EMEA Veterinary Drugs Market: Product Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Anti-infective
Anti-inflammatory
Parasiticides
EMEA Veterinary Drugs Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Livestock
Companion
EMEA Veterinary Drugs Market: Players Segment Analysis (Company and Product introduction, Veterinary Drugs Sales Volume, Revenue, Price and Gross Margin):
Zoetis
Boehringer Ingelheim
Bayer
Elanco Animal Health
Ceva
Dechra
Merck
Virbac
Vetoquinol
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
Veterinary Drugs-EMEA Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Veterinary Drugs industry, standing on the readers’ perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Whole EMEA and Regional Market Size of Veterinary Drugs 2013-2017, and development forecast 2018-2023
Main market players of Veterinary Drugs in EMEA, with company and product introduction, position in the Veterinary Drugs market
Market status and development trend of Veterinary Drugs by types and applications
Cost and profit status of Veterinary Drugs, and marketing status
Market growth drivers and challenges
The report segments the EMEA Veterinary Drugs market as:
EMEA Veterinary Drugs Market: Regional Segment Analysis (Regional Consumption Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
Europe
Middle East
Africa
EMEA Veterinary Drugs Market: Product Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Anti-infective
Anti-inflammatory
Parasiticides
EMEA Veterinary Drugs Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Livestock
Companion
EMEA Veterinary Drugs Market: Players Segment Analysis (Company and Product introduction, Veterinary Drugs Sales Volume, Revenue, Price and Gross Margin):
Zoetis
Boehringer Ingelheim
Bayer
Elanco Animal Health
Ceva
Dechra
Merck
Virbac
Vetoquinol
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
CHAPTER 1 OVERVIEW OF VETERINARY DRUGS
1.1 Definition of Veterinary Drugs in This Report
1.2 Commercial Types of Veterinary Drugs
1.2.1 Anti-infective
1.2.2 Anti-inflammatory
1.2.3 Parasiticides
1.3 Downstream Application of Veterinary Drugs
1.3.1 Livestock
1.3.2 Companion
1.4 Development History of Veterinary Drugs
1.5 Market Status and Trend of Veterinary Drugs 2013-2023
1.5.1 EMEA Veterinary Drugs Market Status and Trend 2013-2023
1.5.2 Regional Veterinary Drugs Market Status and Trend 2013-2023
CHAPTER 2 EMEA MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Status of Veterinary Drugs in EMEA 2013-2017
2.2 Consumption Market of Veterinary Drugs in EMEA by Regions
2.2.1 Consumption Volume of Veterinary Drugs in EMEA by Regions
2.2.2 Revenue of Veterinary Drugs in EMEA by Regions
2.3 Market Analysis of Veterinary Drugs in EMEA by Regions
2.3.1 Market Analysis of Veterinary Drugs in Europe 2013-2017
2.3.2 Market Analysis of Veterinary Drugs in Middle East 2013-2017
2.3.3 Market Analysis of Veterinary Drugs in Africa 2013-2017
2.4 Market Development Forecast of Veterinary Drugs in EMEA 2018-2023
2.4.1 Market Development Forecast of Veterinary Drugs in EMEA 2018-2023
2.4.2 Market Development Forecast of Veterinary Drugs by Regions 2018-2023
CHAPTER 3 EMEA MARKET STATUS AND FORECAST BY TYPES
3.1 Whole EMEA Market Status by Types
3.1.1 Consumption Volume of Veterinary Drugs in EMEA by Types
3.1.2 Revenue of Veterinary Drugs in EMEA by Types
3.2 EMEA Market Status by Types in Major Countries
3.2.1 Market Status by Types in Europe
3.2.2 Market Status by Types in Middle East
3.2.3 Market Status by Types in Africa
3.3 Market Forecast of Veterinary Drugs in EMEA by Types
CHAPTER 4 EMEA MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Demand Volume of Veterinary Drugs in EMEA by Downstream Industry
4.2 Demand Volume of Veterinary Drugs by Downstream Industry in Major Countries
4.2.1 Demand Volume of Veterinary Drugs by Downstream Industry in Europe
4.2.2 Demand Volume of Veterinary Drugs by Downstream Industry in Middle East
4.2.3 Demand Volume of Veterinary Drugs by Downstream Industry in Africa
4.3 Market Forecast of Veterinary Drugs in EMEA by Downstream Industry
CHAPTER 5 MARKET DRIVING FACTOR ANALYSIS OF VETERINARY DRUGS
5.1 EMEA Economy Situation and Trend Overview
5.2 Veterinary Drugs Downstream Industry Situation and Trend Overview
CHAPTER 6 VETERINARY DRUGS MARKET COMPETITION STATUS BY MAJOR PLAYERS IN EMEA
6.1 Sales Volume of Veterinary Drugs in EMEA by Major Players
6.2 Revenue of Veterinary Drugs in EMEA by Major Players
6.3 Basic Information of Veterinary Drugs by Major Players
6.3.1 Headquarters Location and Established Time of Veterinary Drugs Major Players
6.3.2 Employees and Revenue Level of Veterinary Drugs Major Players
6.4 Market Competition News and Trend
6.4.1 Merger, Consolidation or Acquisition News
6.4.2 Investment or Disinvestment News
6.4.3 New Product Development and Launch
CHAPTER 7 VETERINARY DRUGS MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
7.1 Zoetis
7.1.1 Company profile
7.1.2 Representative Veterinary Drugs Product
7.1.3 Veterinary Drugs Sales, Revenue, Price and Gross Margin of Zoetis
7.2 Boehringer Ingelheim
7.2.1 Company profile
7.2.2 Representative Veterinary Drugs Product
7.2.3 Veterinary Drugs Sales, Revenue, Price and Gross Margin of Boehringer Ingelheim
7.3 Bayer
7.3.1 Company profile
7.3.2 Representative Veterinary Drugs Product
7.3.3 Veterinary Drugs Sales, Revenue, Price and Gross Margin of Bayer
7.4 Elanco Animal Health
7.4.1 Company profile
7.4.2 Representative Veterinary Drugs Product
7.4.3 Veterinary Drugs Sales, Revenue, Price and Gross Margin of Elanco Animal Health
7.5 Ceva
7.5.1 Company profile
7.5.2 Representative Veterinary Drugs Product
7.5.3 Veterinary Drugs Sales, Revenue, Price and Gross Margin of Ceva
7.6 Dechra
7.6.1 Company profile
7.6.2 Representative Veterinary Drugs Product
7.6.3 Veterinary Drugs Sales, Revenue, Price and Gross Margin of Dechra
7.7 Merck
7.7.1 Company profile
7.7.2 Representative Veterinary Drugs Product
7.7.3 Veterinary Drugs Sales, Revenue, Price and Gross Margin of Merck
7.8 Virbac
7.8.1 Company profile
7.8.2 Representative Veterinary Drugs Product
7.8.3 Veterinary Drugs Sales, Revenue, Price and Gross Margin of Virbac
7.9 Vetoquinol
7.9.1 Company profile
7.9.2 Representative Veterinary Drugs Product
7.9.3 Veterinary Drugs Sales, Revenue, Price and Gross Margin of Vetoquinol
CHAPTER 8 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF VETERINARY DRUGS
8.1 Industry Chain of Veterinary Drugs
8.2 Upstream Market and Representative Companies Analysis
8.3 Downstream Market and Representative Companies Analysis
CHAPTER 9 COST AND GROSS MARGIN ANALYSIS OF VETERINARY DRUGS
9.1 Cost Structure Analysis of Veterinary Drugs
9.2 Raw Materials Cost Analysis of Veterinary Drugs
9.3 Labor Cost Analysis of Veterinary Drugs
9.4 Manufacturing Expenses Analysis of Veterinary Drugs
CHAPTER 10 MARKETING STATUS ANALYSIS OF VETERINARY DRUGS
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
CHAPTER 11 REPORT CONCLUSION
CHAPTER 12 RESEARCH METHODOLOGY AND REFERENCE
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Reference
1.1 Definition of Veterinary Drugs in This Report
1.2 Commercial Types of Veterinary Drugs
1.2.1 Anti-infective
1.2.2 Anti-inflammatory
1.2.3 Parasiticides
1.3 Downstream Application of Veterinary Drugs
1.3.1 Livestock
1.3.2 Companion
1.4 Development History of Veterinary Drugs
1.5 Market Status and Trend of Veterinary Drugs 2013-2023
1.5.1 EMEA Veterinary Drugs Market Status and Trend 2013-2023
1.5.2 Regional Veterinary Drugs Market Status and Trend 2013-2023
CHAPTER 2 EMEA MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Status of Veterinary Drugs in EMEA 2013-2017
2.2 Consumption Market of Veterinary Drugs in EMEA by Regions
2.2.1 Consumption Volume of Veterinary Drugs in EMEA by Regions
2.2.2 Revenue of Veterinary Drugs in EMEA by Regions
2.3 Market Analysis of Veterinary Drugs in EMEA by Regions
2.3.1 Market Analysis of Veterinary Drugs in Europe 2013-2017
2.3.2 Market Analysis of Veterinary Drugs in Middle East 2013-2017
2.3.3 Market Analysis of Veterinary Drugs in Africa 2013-2017
2.4 Market Development Forecast of Veterinary Drugs in EMEA 2018-2023
2.4.1 Market Development Forecast of Veterinary Drugs in EMEA 2018-2023
2.4.2 Market Development Forecast of Veterinary Drugs by Regions 2018-2023
CHAPTER 3 EMEA MARKET STATUS AND FORECAST BY TYPES
3.1 Whole EMEA Market Status by Types
3.1.1 Consumption Volume of Veterinary Drugs in EMEA by Types
3.1.2 Revenue of Veterinary Drugs in EMEA by Types
3.2 EMEA Market Status by Types in Major Countries
3.2.1 Market Status by Types in Europe
3.2.2 Market Status by Types in Middle East
3.2.3 Market Status by Types in Africa
3.3 Market Forecast of Veterinary Drugs in EMEA by Types
CHAPTER 4 EMEA MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Demand Volume of Veterinary Drugs in EMEA by Downstream Industry
4.2 Demand Volume of Veterinary Drugs by Downstream Industry in Major Countries
4.2.1 Demand Volume of Veterinary Drugs by Downstream Industry in Europe
4.2.2 Demand Volume of Veterinary Drugs by Downstream Industry in Middle East
4.2.3 Demand Volume of Veterinary Drugs by Downstream Industry in Africa
4.3 Market Forecast of Veterinary Drugs in EMEA by Downstream Industry
CHAPTER 5 MARKET DRIVING FACTOR ANALYSIS OF VETERINARY DRUGS
5.1 EMEA Economy Situation and Trend Overview
5.2 Veterinary Drugs Downstream Industry Situation and Trend Overview
CHAPTER 6 VETERINARY DRUGS MARKET COMPETITION STATUS BY MAJOR PLAYERS IN EMEA
6.1 Sales Volume of Veterinary Drugs in EMEA by Major Players
6.2 Revenue of Veterinary Drugs in EMEA by Major Players
6.3 Basic Information of Veterinary Drugs by Major Players
6.3.1 Headquarters Location and Established Time of Veterinary Drugs Major Players
6.3.2 Employees and Revenue Level of Veterinary Drugs Major Players
6.4 Market Competition News and Trend
6.4.1 Merger, Consolidation or Acquisition News
6.4.2 Investment or Disinvestment News
6.4.3 New Product Development and Launch
CHAPTER 7 VETERINARY DRUGS MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
7.1 Zoetis
7.1.1 Company profile
7.1.2 Representative Veterinary Drugs Product
7.1.3 Veterinary Drugs Sales, Revenue, Price and Gross Margin of Zoetis
7.2 Boehringer Ingelheim
7.2.1 Company profile
7.2.2 Representative Veterinary Drugs Product
7.2.3 Veterinary Drugs Sales, Revenue, Price and Gross Margin of Boehringer Ingelheim
7.3 Bayer
7.3.1 Company profile
7.3.2 Representative Veterinary Drugs Product
7.3.3 Veterinary Drugs Sales, Revenue, Price and Gross Margin of Bayer
7.4 Elanco Animal Health
7.4.1 Company profile
7.4.2 Representative Veterinary Drugs Product
7.4.3 Veterinary Drugs Sales, Revenue, Price and Gross Margin of Elanco Animal Health
7.5 Ceva
7.5.1 Company profile
7.5.2 Representative Veterinary Drugs Product
7.5.3 Veterinary Drugs Sales, Revenue, Price and Gross Margin of Ceva
7.6 Dechra
7.6.1 Company profile
7.6.2 Representative Veterinary Drugs Product
7.6.3 Veterinary Drugs Sales, Revenue, Price and Gross Margin of Dechra
7.7 Merck
7.7.1 Company profile
7.7.2 Representative Veterinary Drugs Product
7.7.3 Veterinary Drugs Sales, Revenue, Price and Gross Margin of Merck
7.8 Virbac
7.8.1 Company profile
7.8.2 Representative Veterinary Drugs Product
7.8.3 Veterinary Drugs Sales, Revenue, Price and Gross Margin of Virbac
7.9 Vetoquinol
7.9.1 Company profile
7.9.2 Representative Veterinary Drugs Product
7.9.3 Veterinary Drugs Sales, Revenue, Price and Gross Margin of Vetoquinol
CHAPTER 8 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF VETERINARY DRUGS
8.1 Industry Chain of Veterinary Drugs
8.2 Upstream Market and Representative Companies Analysis
8.3 Downstream Market and Representative Companies Analysis
CHAPTER 9 COST AND GROSS MARGIN ANALYSIS OF VETERINARY DRUGS
9.1 Cost Structure Analysis of Veterinary Drugs
9.2 Raw Materials Cost Analysis of Veterinary Drugs
9.3 Labor Cost Analysis of Veterinary Drugs
9.4 Manufacturing Expenses Analysis of Veterinary Drugs
CHAPTER 10 MARKETING STATUS ANALYSIS OF VETERINARY DRUGS
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
CHAPTER 11 REPORT CONCLUSION
CHAPTER 12 RESEARCH METHODOLOGY AND REFERENCE
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Reference
